mavatrep receptor selective competitive investigational analgesic may potential treatment analgesia andor inflammation phase trials completed healthy japanese caucasian potential common adverse effects include thermohypoesthesia chills feeling cold feeling administered orally day mavatrep reached steadystate healthy volunteers approximately relatively long half life hours japanese subjects hours caucasian mavatrep largely eliminated nonrenally mavatrep appears metabolized two primary metabolites also eliminated httpsenwikipediaorgwikimavatrep